Prim is forecast to grow revenue at 6.3% per annum. EPS is expected to grow by 12.2% per annum.
Key information
n/a
Earnings growth rate
12.16%
EPS growth rate
Medical Equipment earnings growth
13.6%
Revenue growth rate
6.3%
Future return on equity
14.55%
Analyst coverage
Low
Last updated
30 Mar 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:5P1 - Analysts future estimates and past financials data (EUR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
304
N/A
N/A
N/A
1
12/31/2027
290
N/A
N/A
N/A
1
12/31/2026
271
N/A
N/A
N/A
1
12/31/2025
252
17
18
30
N/A
9/30/2025
246
16
22
34
N/A
6/30/2025
241
15
25
37
N/A
3/31/2025
237
13
18
29
N/A
12/31/2024
233
11
11
22
N/A
9/30/2024
230
11
-15
-6
N/A
6/30/2024
228
11
-41
-34
N/A
3/31/2024
222
12
-31
-23
N/A
12/31/2023
217
13
-22
-11
N/A
9/30/2023
212
11
-8
4
N/A
6/30/2023
207
10
6
19
N/A
3/31/2023
202
9
0
12
N/A
12/31/2022
197
8
-7
5
N/A
9/30/2022
192
11
-5
10
N/A
6/30/2022
186
14
-4
14
N/A
3/31/2022
181
15
N/A
N/A
N/A
12/31/2021
169
17
12
24
N/A
9/30/2021
168
15
N/A
N/A
N/A
6/30/2021
161
14
22
28
N/A
3/31/2021
146
10
N/A
N/A
N/A
12/31/2020
147
7
19
25
N/A
9/30/2020
147
11
N/A
N/A
N/A
6/30/2020
143
9
3
13
N/A
3/31/2020
154
11
N/A
N/A
N/A
12/31/2019
151
11
-7
-1
N/A
9/30/2019
146
12
N/A
N/A
N/A
6/30/2019
142
13
N/A
-4
N/A
3/31/2019
137
14
N/A
N/A
N/A
12/31/2018
134
14
N/A
7
N/A
9/30/2018
132
14
N/A
N/A
N/A
6/30/2018
128
14
N/A
10
N/A
3/31/2018
124
15
N/A
N/A
N/A
12/31/2017
121
14
N/A
11
N/A
9/30/2017
117
14
N/A
N/A
N/A
6/30/2017
116
14
N/A
8
N/A
3/31/2017
114
13
N/A
N/A
N/A
12/31/2016
110
13
N/A
10
N/A
9/30/2016
107
11
N/A
N/A
N/A
6/30/2016
106
11
N/A
14
N/A
3/31/2016
102
11
N/A
N/A
N/A
12/31/2015
99
11
N/A
10
N/A
9/30/2015
99
11
N/A
N/A
N/A
6/30/2015
97
11
N/A
7
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 5P1's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if 5P1's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 5P1's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 5P1's revenue (6.3% per year) is forecast to grow slower than the German market (6.7% per year).
High Growth Revenue: 5P1's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 5P1's Return on Equity is forecast to be low in 3 years time (14.5%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/16 23:38
End of Day Share Price
2026/06/16 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prim, S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.